Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
5.26
-1.84 (-25.92%)
At close: Nov 10, 2026, 4:00 PM EST
5.53
+0.27 (5.13%)
Pre-market: Nov 11, 2026, 8:44 AM EST
Exagen Market Cap
Exagen has a market cap or net worth of $127.43 million as of November 10, 2026. It is the 23,344th most valuable company in the world and the 3,877th biggest in the United States. Its market cap has decreased by 41.19% in one year.
Market Cap
127.43M
Enterprise Value
128.09M
1-Year Change
-41.19%
Global Rank
Country Rank
#3,877 United States
Category
ChartMarket Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $127.43M, an increase of 101.92%. That is a compound annual growth rate of 10.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 127.43M | -7.52% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 1.27B |
| Freenome | 1.16B |
| Castle Biosciences | 1.06B |
| Fulgent Genetics | 719.99M |
| Myriad Genetics | 543.88M |
| Burning Rock Biotech | 137.95M |
| Biodesix | 111.44M |
| Insight Molecular Diagnostics | 80.50M |